We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLSD
876
DELISTED
Clearside Biomedical
CLSD
| $282K | ﹤0.01% |
+3,059
| New | +$364K |
|
|
CGRN
877
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $279K | ﹤0.01% |
27,851
+9,443
| +51% | +$121K |
|
878
Protagonist Therapeutics
PTGX
$8.75B
| $273K | ﹤0.01% |
+26,500
| New | +$228K |
|
879
Movado Group
MOV
$812M
| $272K | ﹤0.01% |
6,500
-2,931
| -31% | -$137K |
|
|
CUTR
880
DELISTED
Cutera, Inc.
CUTR
| $272K | ﹤0.01% |
8,345
-50,976
| -86% | -$1.86M |
|
|
BFIN
881
DELISTED
BankFinancial
BFIN
| $271K | ﹤0.01% |
17,000
+3,300
| +24% | +$54.4K |
|
882
CDW
CDW
$17.1B
| $270K | ﹤0.01% |
+3,040
| New | +$263K |
|
883
United Fire Group
UFCS
$1.32B
| $270K | ﹤0.01% |
5,320
+500
| +10% | +$26.7K |
|
|
VTLE
884
DELISTED
Vital Energy
VTLE
| $270K | ﹤0.01% |
+1,650
| New | +$289K |
|
885
Autodesk
ADSK
$44.3B
| $269K | ﹤0.01% |
1,720
-2,480
| -59% | -$350K |
|
|
TGH
886
DELISTED
Textainer Group Holdings limited
TGH
| $266K | ﹤0.01% |
20,771
-4,700
| -18% | -$69.1K |
|
|
AINC
887
DELISTED
Ashford Inc.
AINC
| $265K | ﹤0.01% |
3,487
-590
| -14% | -$48.8K |
|
|
OSG
888
DELISTED
Overseas Shipholding Group Inc.
OSG
| $264K | ﹤0.01% |
83,948
+34,100
| +68% | +$119K |
|
889
First Mid Bancshares
FMBH
$1.36B
| $263K | ﹤0.01% |
+6,519
| New | +$266K |
|
890
Pultegroup
PHM
$24.5B
| $263K | ﹤0.01% |
10,620
-8,250
| -44% | -$234K |
|
891
Home Bancorp
HBCP
$552M
| $262K | ﹤0.01% |
+6,026
| New | +$274K |
|
892
Masco
MAS
$16B
| $261K | ﹤0.01% |
7,130
-11,640
| -62% | -$448K |
|
|
CNR
893
Core Natural Resources Inc
CNR
$4.19B
| $261K | ﹤0.01% |
+6,400
| New | +$269K |
|
894
Vornado Realty Trust
VNO
$7.47B
| $260K | ﹤0.01% |
3,560
-17,000
| -83% | -$1.26M |
|
|
SCTL
895
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $259K | ﹤0.01% |
40,657
-669
| -2% | -$3.79K |
|
896
Emergent Biosolutions
EBS
$375M
| $255K | ﹤0.01% |
3,880
-1,800
| -32% | -$105K |
|
897
Domo
DOMO
$166M
| $245K | ﹤0.01% |
+11,400
| New | +$226K |
|
|
AMBR
898
DELISTED
Amber Road Inc
AMBR
| $244K | ﹤0.01% |
25,400
-200
| -0.8% | -$1.78K |
|
|
PFSW
899
DELISTED
PFSweb, Inc.
PFSW
| $244K | ﹤0.01% |
32,950
+19,150
| +139% | +$172K |
|
|
CSW
900
CSW Industrials
CSW
$4.71B
| $242K | ﹤0.01% |
4,510
| – | – |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.